SCHEMBL18583408

SCHEMBL18583408

C#CCc1ccc2c(c1)n(Cc1ccc(OC)cc1)c(=O)n2CC(=O)OC(C)(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.42
▸ KMT2A Q03164 3/20 0.42
▸ TSPO P30536 3/20 0.39
▸ OPRM1 P35372 1/20 0.38
▸ OPRL1 P41146 1/20 0.38
▸ CCR2 P41597 1/20 0.38
▸ PRMT5 O14744 2/20 0.38
▸ WDR77 Q9BQA1 2/20 0.38
▸ CASR P41180 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ PDE1A P54750 1/20 0.37
▸ PDE1B Q01064 1/20 0.37
▸ PDE1C Q14123 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ MAPT P10636 1/20 0.36
▸ PARG Q86W56 1/20 0.36
▸ HDAC1 Q13547 1/20 0.36
▸ HDAC11 Q96DB2 1/20 0.36
▸ HDAC8 Q9BY41 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24093939 0.85 MEN1 (0.44) MEN1KMT2AOPRM1OPRL1CCR2
SCHEMBL18171825 0.81 GRM2 (0.51) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL18555694 0.74 PRMT5 (0.46) MEN1KMT2ACCR2PRMT5WDR77
SCHEMBL2762363 0.74 ALDH1A1 (0.54) MEN1KMT2AALDH1A1KDM4ETSHR
SCHEMBL18171783 0.72 ALDH1A1 (0.46) MEN1KMT2AALDH1A1KDM4E
SCHEMBL18555697 0.70 PTGS2 (0.52) MEN1KMT2ACCR2PDE1B
SCHEMBL18171826 0.70 ALDH1A1 (0.45) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL11263773 0.70 MEN1 (0.72) MEN1KMT2AALDH1A1KDM4ETSHR
SCHEMBL32674290 0.69 MIF (0.56) MEN1KMT2AALDH1A1KDM4ETSHR
SCHEMBL11257792 0.69 MEN1 (0.64) MEN1KMT2AMAPTHDAC1HDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017035415-A1 ALKYNE COMPOUNDS FOR TREATMENT OF IMMUNE AND INFLAMMATORY DISORDERS ACHILLION PHARMACEUTICALS, INC. (US) 2017-03-02 — — WO disclosed
Send feedback